Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories Q3 adj. earnings rise on higher sales; meet Street view
Abbott Laboratories (NYSE: ABT) reported higher sales and adjusted earnings for the third quarter of fiscal 2025. The healthcare company also reaffirmed its full-year 2025 guidance.
Total sales increased 6.9% year-over-year to $11.37 billion in the third quarter, which is broadly in line with analysts’ estimates. Organic sales grew 5.5%, or 7.5% excluding COVID-19 testing-related sales.
Adjusted earnings rose to $1.30 per share in Q3 from $1.21 per share in the year-ago quarter, matching market watchers’ expectations. Unadjusted net income was $1.64 billion or $0.94 per share in the third quarter, unchanged from the profit reported in Q3 2024.
The Abbott leadership reaffirmed the midpoint of its previously provided full-year 2025 adjusted earnings per share guidance, narrowing the range to $5.12 to $5.18.
“Our third-quarter results demonstrate our ability to deliver consistent, high-quality performance. Our differentiated product pipeline continues to power our performance and positions Abbott to deliver durable long-term value to our shareholders,” said Robert Ford, chief executive officer of Abbott.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
